Orinove, Inc.
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Evaluation of Oral ORIN1001 in Subjects With Idiopathic Pulmonary Fibrosis (IPF) (NCT04643769) | Orinove, Inc. | 2021-02-09 |
| Treatment of Patients With Advanced Solid Tumors With Oral Agent ORIN1001 and in Combination With Standard of Care. (NCT05154201) | Orinove, Inc. | 2020-07-01 |
| ORIN1001 in Patients with Advanced Solid Tumors and Relapsed Refractory Metastatic Breast Cancer (NCT03950570) | Orinove, Inc. | 2019-05-25 |
Track Orinove, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.